GlassScriptPhysician profile
Craig Callam
NPI 1538799747
$4,411.96
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $305 · 2022: $1,450 · 2023: $2,142 · 2024: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,657.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,582.39 | 2021-2024 | Dovato, Apretude, Cabenuva |
| Abbvie INC. | $719.95 | 2021-2024 | |
| Gilead Sciences, INC. | $708.76 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $293.35 | 2021-2024 | Delstrigo, Pifeltro, Dificid |
| Theratechnologies INC. | $241.20 | 2021-2023 | Trogarzo, Egrifta |
| Janssen Biotech, INC. | $235.80 | 2022-2023 | Prezcobix, Symtuza |
| Alkermes, INC. | $212.63 | 2023 | Lybalvi |
| Napo Pharmaceuticals INC | $145.88 | 2022-2024 | Mytesi |
| Lilly USA, LLC | $89.88 | 2022-2023 | Mounjaro |
| Novo Nordisk INC | $36.17 | 2023 | Rybelsus, Ozempic |
| Phadia US INC. | $24.82 | 2023 | Immunocap |
| Glaxosmithkline, LLC. | $20.84 | 2021 | |
| Axsome Therapeutics, INC. | $20.03 | 2023 | Auvelity |
| Pfizer INC. | $17.47 | 2022 | |
| Paratek Pharmaceuticals, INC. | $17.02 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $16.69 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.94 | 2022 | |
| Currax Pharmaceuticals LLC | $13.14 | 2023 | Onzetra Xsail, Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Callam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.